← Back to Screener
Alignment Healthcare, Inc. Common Stock (ALHC)
Price$20.82
Favorite Metrics
Price vs S&P 500 (26W)14.27%
Price vs S&P 500 (4W)9.19%
Market Capitalization$4.27B
All Metrics
P/CF (Annual)30.54x
Book Value / Share (Quarterly)$0.88
P/TBV (Annual)22.62x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)40.16%
Cash Flow / Share (Quarterly)$0.55
Price vs S&P 500 (YTD)3.28%
Gross Margin (TTM)12.37%
Net Profit Margin (TTM)-0.02%
EPS (TTM)$-0.01
10-Day Avg Trading Volume3.83M
EPS Excl Extra (TTM)$-0.01
Revenue Growth (5Y)32.71%
EPS (Annual)$-0.00
ROI (Annual)-0.14%
Gross Margin (Annual)12.37%
Net Profit Margin (5Y Avg)-8.00%
Cash / Share (Quarterly)$2.96
Revenue Growth QoQ (YoY)44.43%
ROA (Last FY)-0.07%
Revenue Growth TTM (YoY)46.06%
EBITD / Share (TTM)$0.22
ROE (5Y Avg)-69.91%
Operating Margin (TTM)0.37%
Cash Flow / Share (Annual)$0.55
P/B Ratio23.84x
P/B Ratio (Quarterly)22.04x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.02x
Net Interest Coverage (TTM)0.94x
ROA (TTM)-0.07%
EV / EBITDA (TTM)88.88x
EPS Incl Extra (Annual)$-0.00
Current Ratio (Annual)1.71x
Quick Ratio (Quarterly)1.54x
3-Month Avg Trading Volume3.02M
52-Week Price Return9.36%
EV / Free Cash Flow (Annual)35.54x
Revenue / Employee (TTM)$2
Tangible BV / Share (Quarterly)$0.86
P/S Ratio (Annual)1.08x
Asset Turnover (Annual)3.71x
52-Week High$23.87
Operating Margin (5Y Avg)-6.98%
EPS Excl Extra (Annual)$-0.00
CapEx CAGR (5Y)11.26%
26-Week Price Return18.26%
Quick Ratio (Annual)1.54x
13-Week Price Return-1.69%
Total Debt / Equity (Annual)1.80x
Current Ratio (Quarterly)1.71x
Enterprise Value$4,021.242
Revenue / Share Growth (5Y)31.24%
Asset Turnover (TTM)3.89x
Revenue / Employee (Annual)$2
Pretax Margin (Annual)-0.02%
Cash / Share (Annual)$2.96
3-Month Return Std Dev57.56%
Gross Margin (5Y Avg)11.65%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)37.82%
EBITDA Interim CAGR (5Y)-5.25%
ROE (Last FY)-0.40%
Net Interest Coverage (Annual)0.94x
EPS Basic Excl Extra (Annual)$-0.00
P/FCF (TTM)25.36x
Receivables Turnover (TTM)39.26x
EV / Free Cash Flow (TTM)35.54x
Total Debt / Equity (Quarterly)1.80x
EPS Incl Extra (TTM)$-0.01
Receivables Turnover (Annual)39.26x
ROI (TTM)-0.15%
P/S Ratio (TTM)1.08x
Pretax Margin (5Y Avg)-8.00%
Revenue / Share (Annual)$19.94
Tangible BV / Share (Annual)$0.86
Forward P/E159.88x
Price vs S&P 500 (52W)-20.47%
Year-to-Date Return5.92%
5-Day Price Return-2.15%
EPS Normalized (Annual)$-0.00
ROA (5Y Avg)-19.20%
Net Profit Margin (Annual)-0.02%
Month-to-Date Return18.73%
Cash Flow / Share (TTM)$-0.74
EBITD / Share (Annual)$0.23
Operating Margin (Annual)0.37%
LT Debt / Equity (Annual)1.80x
P/CF (TTM)30.54x
ROI (5Y Avg)-31.42%
LT Debt / Equity (Quarterly)1.80x
EPS Basic Excl Extra (TTM)$-0.01
P/TBV (Quarterly)22.62x
P/B Ratio (Annual)22.04x
Pretax Margin (TTM)-0.02%
Book Value / Share (Annual)$0.88
Price vs S&P 500 (13W)-2.38%
Beta1.22x
P/FCF (Annual)37.77x
Revenue / Share (TTM)$19.64
ROE (TTM)-0.49%
52-Week Low$11.63
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.26
4.26
4.26
4.26
Industry Peers — Hospital & Medical Insurance(9)
| Symbol | P/B Ratio (Quarterly) | ROE (TTM) | Indicated Dividend Yield (Annual) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ALHCAlignment Healthcare, Inc. Common Stock | 22.04x | -0.49% | — | 0.37% | $20.82 |
UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | 2.99x | 12.50% | 2.81% | 4.18% | $316.40 |
CIThe Cigna Group | 1.76x | 14.53% | 2.32% | 3.35% | $276.37 |
ELVElevance Health, Inc. | 1.78x | 13.01% | 2.21% | 4.07% | $315.82 |
HUMHumana Inc. | 1.74x | 6.59% | 1.78% | 2.03% | $200.76 |
CNCCentene Corporation | 1.01x | -27.74% | — | -3.91% | $39.00 |
MOHMolina Healthcare, Inc. | 2.19x | 10.99% | — | 1.72% | $148.87 |
OSCROscar Health, Inc. | 3.89x | -39.45% | — | -3.39% | $15.63 |
TRUPTrupanion, Inc. | 4.20x | 5.39% | — | 0.98% | $27.75 |
CLOVClover Health Investments, Corp | 3.93x | -25.73% | — | -4.44% | $2.16 |
About
Alignment Healthcare Inc markets and sells Medicare Advantage plans directly to senior consumers, allowing beneficiaries to select their coverage annually. The company operates an integrated platform combining technology and clinical care management to deliver health plans and services. This direct-to-consumer model aims to improve health outcomes and operational efficiency in the Medicare market.